tenk.fyi

Cullinan Therapeutics, Inc.

CGEMNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$219.9M

31.4% YoY

EPS

-

Cash

$88.3M

6.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro